1
|
Oblak ML, Lu HY, Ram AS, McKenna C. Comparative aspects of targeted sentinel lymph node mapping in veterinary and human medicine: opportunities for future research. Front Med (Lausanne) 2024; 11:1342456. [PMID: 38633313 PMCID: PMC11021648 DOI: 10.3389/fmed.2024.1342456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2023] [Accepted: 02/29/2024] [Indexed: 04/19/2024] Open
Abstract
There is a significant overlap in the genetic, metabolic and epigenetic alterations between human and companion animal cancers, including those of the oral cavity, breast, bladder, skin, lungs and pancreas. In many cancer types, the identification and removal of affected lymph nodes are essential for accurate cancer management, including treatment and prognosis. Historically, lymphadenectomy and subsequent radical resection based on regional anatomy, palpation and lymph node aspirates were considered sufficient; however, modern approaches with sentinel lymph node mapping (SLN) mapping have increased the accuracy of surgical decision-making. Preoperative and intraoperative SLN mapping techniques in veterinary patients parallel those used in human medicine. While many of these techniques are highly successful, the main challenges with current methodologies are their sensitivity and specificity for the presence of cancer, which can be overcome via precision medicine and targeted SLN mapping agents. Given the large population of dogs and cats with cancer, the crossover of knowledge between species can help to deepen our understanding of many of these cancers and can be useful in evaluating new drugs and/or therapies. In this review, we discuss SLN mapping techniques in veterinary medicine and the concept of precision medicine as it relates to targeted SLN mapping imaging agents. The large number of companion animals affected by cancer is an underutilized resource to bridge the translational gap and we aim to provide a reference for the use of dogs and cats as a comparative model for human SLN mapping.
Collapse
Affiliation(s)
- Michelle L. Oblak
- Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada
| | - Hui Yu Lu
- Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada
| | - Ann S. Ram
- Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada
| | - Charly McKenna
- Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada
| |
Collapse
|
2
|
Bray J, Eward W, Breen M. Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk. Vet Comp Oncol 2023; 21:145-158. [PMID: 36745110 DOI: 10.1111/vco.12881] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2022] [Revised: 12/03/2022] [Accepted: 02/03/2023] [Indexed: 02/07/2023]
Abstract
Due to the complex nature of tumour biology and the integration between host tissues and molecular processes of the tumour cells, a continued reliance on the status of the microscopic cellular margin should not remain our only determinant of the success of a curative-intent surgery for patients with cancer. Based on current evidence, relying on a purely cellular focus to provide a binary indication of treatment success can provide an incomplete interpretation of potential outcome. A more holistic analysis of the cancer margin may be required. If we are to move ahead from our current situation - and allow treatment plans to be more intelligently tailored to meet the requirements of each individual tumour - we need to improve our utilisation of techniques that either improve recognition of residual tumour cells within the surgical field or enable a more comprehensive interrogation of tumour biology that identifies a risk of recurrence. In the second article in this series on defining the relevance of surgical margins, the authors discuss possible alternative strategies for margin assessment and evaluation in the canine and feline cancer patient. These strategies include considering adoption of the residual tumour classification scheme; intra-operative imaging systems including fluorescence-guided surgery, optical coherence tomography and Raman spectroscopy; molecular analysis and whole transcriptome analysis of tissues; and the development of a biologic index (nomogram). These techniques may allow evaluation of individual tumour biology and the status of the resection margin in ways that are different to our current techniques. Ultimately, these techniques seek to better define the risk of tumour recurrence following surgery and provide the surgeon and patient with more confidence in margin assessment.
Collapse
Affiliation(s)
| | - Will Eward
- Orthopedic Surgical Oncologist, Duke Cancer Center, Durham, North Carolina, USA
| | - Matthew Breen
- Oscar J. Fletcher Distinguished Professor of Comparative Oncology Genetics, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA
| |
Collapse
|
3
|
Josserand V, Bernard C, Michy T, Guidetti M, Vollaire J, Coll JL, Hurbin A. Tumor-Specific Imaging with Angiostamp800 or Bevacizumab-IRDye 800CW Improves Fluorescence-Guided Surgery over Indocyanine Green in Peritoneal Carcinomatosis. Biomedicines 2022; 10:biomedicines10051059. [PMID: 35625796 PMCID: PMC9138305 DOI: 10.3390/biomedicines10051059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2022] [Revised: 04/28/2022] [Accepted: 04/29/2022] [Indexed: 11/16/2022] Open
Abstract
Complete surgical removal of lesions improves survival of peritoneal carcinomatosis and can be enhanced by intraoperative near-infrared fluorescence imaging. Indocyanine green (ICG) is the only near-infrared fluorescent dye approved for clinical use, but it lacks specificity for tumor cells, highlighting the need for tumor-selective targeting agents. We compared the tumor-specific near-infrared fluorescent probes Bevacizumab-IRDye 800CW and Angiostamp800, which target tumor angiogenesis and cancer cells, to ICG for fluorescence-guided surgery in peritoneal carcinomatosis of ovarian origin. The probes were administered to mice with orthotopic peritoneal carcinomatosis prior to conventional and fluorescence-guided surgery. The influence of neoadjuvant chemotherapy was also assessed. Conventional surgery removed 88.0 ± 1.2% of the total tumor load in mice. Fluorescence-guided surgery allowed the resection of additional nodules, enhancing the total tumor burden resection by 9.8 ± 0.7%, 8.5 ± 0.8%, and 3.9 ± 1.2% with Angiostamp800, Bevacizumab-IRDye 800CW and ICG, respectively. Interestingly, among the resected nodules, 15% were false-positive with ICG, compared to only 1.4% with Angiostamp800 and 3.5% with Bevacizumab-IRDye 800CW. Furthermore, conventional surgery removed only 69.0 ± 3.9% of the total tumor burden after neoadjuvant chemotherapy. Fluorescence-guided surgery with Angiostamp800 and Bevacizumab-IRDye 800CW increased the total tumor burden resection to 88.7 ± 4.3%, whereas ICG did not improve surgery at all. Bevacizumab-IRDye 800CW and Angiostamp800 better detect ovarian tumors and metastases than the clinically used fluorescent tracer ICG, and can help surgeons completely remove tumors, especially after surgery neoadjuvant chemotherapy.
Collapse
Affiliation(s)
- Véronique Josserand
- Institute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale INSERM U1209, Centre National de la Recherche Scientifique CNRS UMR5309, Université Grenoble Alpes, F-38000 Grenoble, France; (V.J.); (C.B.); (T.M.); (M.G.); (J.V.); (J.-L.C.)
| | - Claire Bernard
- Institute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale INSERM U1209, Centre National de la Recherche Scientifique CNRS UMR5309, Université Grenoble Alpes, F-38000 Grenoble, France; (V.J.); (C.B.); (T.M.); (M.G.); (J.V.); (J.-L.C.)
- Centre Hospitalier Universitaire Grenoble Alpes, Université Grenoble Alpes, F-38000 Grenoble, France
| | - Thierry Michy
- Institute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale INSERM U1209, Centre National de la Recherche Scientifique CNRS UMR5309, Université Grenoble Alpes, F-38000 Grenoble, France; (V.J.); (C.B.); (T.M.); (M.G.); (J.V.); (J.-L.C.)
- Centre Hospitalier Universitaire Grenoble Alpes, Université Grenoble Alpes, F-38000 Grenoble, France
| | - Mélanie Guidetti
- Institute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale INSERM U1209, Centre National de la Recherche Scientifique CNRS UMR5309, Université Grenoble Alpes, F-38000 Grenoble, France; (V.J.); (C.B.); (T.M.); (M.G.); (J.V.); (J.-L.C.)
| | - Julien Vollaire
- Institute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale INSERM U1209, Centre National de la Recherche Scientifique CNRS UMR5309, Université Grenoble Alpes, F-38000 Grenoble, France; (V.J.); (C.B.); (T.M.); (M.G.); (J.V.); (J.-L.C.)
| | - Jean-Luc Coll
- Institute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale INSERM U1209, Centre National de la Recherche Scientifique CNRS UMR5309, Université Grenoble Alpes, F-38000 Grenoble, France; (V.J.); (C.B.); (T.M.); (M.G.); (J.V.); (J.-L.C.)
| | - Amandine Hurbin
- Institute for Advanced Biosciences, Institut National de la Santé et de la Recherche Médicale INSERM U1209, Centre National de la Recherche Scientifique CNRS UMR5309, Université Grenoble Alpes, F-38000 Grenoble, France; (V.J.); (C.B.); (T.M.); (M.G.); (J.V.); (J.-L.C.)
- Correspondence:
| |
Collapse
|
4
|
Ludwig BS, Kessler H, Kossatz S, Reuning U. RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving Field. Cancers (Basel) 2021; 13:cancers13071711. [PMID: 33916607 PMCID: PMC8038522 DOI: 10.3390/cancers13071711] [Citation(s) in RCA: 92] [Impact Index Per Article: 30.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2021] [Revised: 03/22/2021] [Accepted: 03/29/2021] [Indexed: 12/19/2022] Open
Abstract
Simple Summary Integrins, a superfamily of cell adhesion receptors, were extensively investigated as therapeutic targets over the last decades, motivated by their multiple functions, e.g., in cancer (progression, metastasis, angiogenesis), sepsis, fibrosis, and viral infections. Although integrin-targeting clinical trials, especially in cancer, did not meet the high expectations yet, integrins remain highly interesting therapeutic targets. In this article, we analyze the state-of-the-art knowledge on the roles of a subfamily of integrins, which require binding of the tripeptide motif Arg-Gly-Asp (RGD) for cell adhesion and signal transduction, in cancer, in tumor-associated exosomes, in fibrosis and SARS-CoV-2 infection. Furthermore, we outline the latest achievements in the design and development of synthetic ligands, which are highly selective and affine to single integrin subtypes, i.e., αvβ3, αvβ5, α5β1, αvβ6, αvβ8, and αvβ1. Lastly, we present the substantial progress in the field of nuclear and optical molecular imaging of integrins, including first-in-human and clinical studies. Abstract Integrins have been extensively investigated as therapeutic targets over the last decades, which has been inspired by their multiple functions in cancer progression, metastasis, and angiogenesis as well as a continuously expanding number of other diseases, e.g., sepsis, fibrosis, and viral infections, possibly also Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2). Although integrin-targeted (cancer) therapy trials did not meet the high expectations yet, integrins are still valid and promising targets due to their elevated expression and surface accessibility on diseased cells. Thus, for the future successful clinical translation of integrin-targeted compounds, revisited and innovative treatment strategies have to be explored based on accumulated knowledge of integrin biology. For this, refined approaches are demanded aiming at alternative and improved preclinical models, optimized selectivity and pharmacological properties of integrin ligands, as well as more sophisticated treatment protocols considering dose fine-tuning of compounds. Moreover, integrin ligands exert high accuracy in disease monitoring as diagnostic molecular imaging tools, enabling patient selection for individualized integrin-targeted therapy. The present review comprehensively analyzes the state-of-the-art knowledge on the roles of RGD-binding integrin subtypes in cancer and non-cancerous diseases and outlines the latest achievements in the design and development of synthetic ligands and their application in biomedical, translational, and molecular imaging approaches. Indeed, substantial progress has already been made, including advanced ligand designs, numerous elaborated pre-clinical and first-in-human studies, while the discovery of novel applications for integrin ligands remains to be explored.
Collapse
Affiliation(s)
- Beatrice S. Ludwig
- Department of Nuclear Medicine, University Hospital Klinikum Rechts der Isar and Central Institute for Translational Cancer Research (TranslaTUM), Technical University Munich, 81675 Munich, Germany;
| | - Horst Kessler
- Department of Chemistry, Institute for Advanced Study, Technical University Munich, 85748 Garching, Germany;
| | - Susanne Kossatz
- Department of Nuclear Medicine, University Hospital Klinikum Rechts der Isar and Central Institute for Translational Cancer Research (TranslaTUM), Technical University Munich, 81675 Munich, Germany;
- Department of Chemistry, Institute for Advanced Study, Technical University Munich, 85748 Garching, Germany;
- Correspondence: (S.K.); (U.R.); Tel.: +49-89-4140-9134 (S.K.); +49-89-4140-7407 (U.R.)
| | - Ute Reuning
- Clinical Research Unit, Department of Obstetrics and Gynecology, University Hospital Klinikum Rechts der Isar, Technical University Munich, 81675 Munich, Germany
- Correspondence: (S.K.); (U.R.); Tel.: +49-89-4140-9134 (S.K.); +49-89-4140-7407 (U.R.)
| |
Collapse
|
5
|
Expression of Platelet Derived Growth Factor a, Its Receptor, and Integrin Subunit Alpha V in Feline Injection-Site Sarcomas. ACTA VET-BEOGRAD 2021. [DOI: 10.2478/acve-2021-0002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Abstract
Injection-site sarcomas are considered an important entity in veterinary oncology, especially in cats. The current study investigated the immunohistochemical expression of platelet-derived growth factor A (PDGFA), platelet-derived growth factor receptor-α (PDGFR-α), and integrin alpha subunit v in feline injection-site sarcomas (FISS). A total of 14 paraffin-embedded tissue samples previously diagnosed as soft tissue sarcomas were selected from the departmental archive and sectioned at 5µm using a microtome. Tissue sections were stained with Hematoxylin & Eosin, Alcian blue-Periodic Acid Schiff (AB-PAS), Masson’s Trichrome, and immunohistochemically for PDGFA, PDGR-α, and integrin alpha v. The majority of the tumors were fibrosarcomas (n=13/14), except one case of myxoid liposarcoma. The tumors occurred at sites commonly used for injections or vaccine administration. Histologically, tumors were characterized by peripheral infiltration of mononuclear cells mainly lymphocytes, variable sized central necrotic areas, and many multinucleated tumor giant cells. AB-PAS staining revealed the presence of myxoid or mucinous areas in (8/14) tumors while trichrome staining demonstrated a variable amount of collagenous stroma in 12/14 tumors. Vimentin immunoreactivity was observed in all the tumors while smooth muscle actin and muscle actin staining was noticed in four and two cases, respectively. PDGFA and PDGFR-α immunoexpression was observed in all 14 cases while integrin alpha v in 13/14 cases. The results of the current study indicate that fibrosarcoma is the major morphologic phenotype of FISS. The PDGFA, its receptor, and integrin alpha v immunoexpression are increased in these tumors in cats which elucidates their role in the pathogenesis of FISS.
Collapse
|
6
|
Cepeda C, Raibaut L, Fremy G, Eliseeva SV, Romieu A, Pécaut J, Boturyn D, Petoud S, Sénèque O. Using Native Chemical Ligation for Site‐Specific Synthesis of Hetero‐bis‐lanthanide Peptide Conjugates: Application to Ratiometric Visible or Near‐Infrared Detection of Zn
2+. Chemistry 2020; 26:13476-13483. [DOI: 10.1002/chem.202002708] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2020] [Indexed: 01/28/2023]
Affiliation(s)
- Céline Cepeda
- Univ. Grenoble Alpes CNRS, CEA, IRIG, LCBM (UMR 5249) 38000 Grenoble France
- Univ. Grenoble Alpes CNRS, DCM (UMR 5250) 38000 Grenoble France
| | - Laurent Raibaut
- Univ. Grenoble Alpes CNRS, CEA, IRIG, LCBM (UMR 5249) 38000 Grenoble France
| | - Guillaume Fremy
- Univ. Grenoble Alpes CNRS, CEA, IRIG, LCBM (UMR 5249) 38000 Grenoble France
- Univ. Grenoble Alpes CNRS, DCM (UMR 5250) 38000 Grenoble France
| | | | - Anthony Romieu
- ICMUB UMR 6302 CNRS Univ. Bourgogne Franche-Comté 21000 Dijon France
| | - Jacques Pécaut
- Univ. Grenoble Alpes CEA CNRS, IRIG SyMMES 38000 Grenoble France
| | - Didier Boturyn
- Univ. Grenoble Alpes CNRS, DCM (UMR 5250) 38000 Grenoble France
| | - Stéphane Petoud
- Centre de Biophysique Moléculaire CNRS UPR 4301 45071 Orléans France
| | - Olivier Sénèque
- Univ. Grenoble Alpes CNRS, CEA, IRIG, LCBM (UMR 5249) 38000 Grenoble France
| |
Collapse
|
7
|
Favril S, Brioschi C, Vanderperren K, Abma E, Stock E, Devriendt N, Polis I, De Cock H, Cordaro A, Miragoli L, Oliva P, Valbusa G, Alleaume C, Tardy I, Maiocchi A, Tedoldi F, Blasi F, de Rooster H. Preliminary safety and imaging efficacy of the near-infrared fluorescent contrast agent DA364 during fluorescence-guided surgery in dogs with spontaneous superficial tumors. Oncotarget 2020; 11:2310-2326. [PMID: 32595830 PMCID: PMC7299531 DOI: 10.18632/oncotarget.27633] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2020] [Accepted: 05/14/2020] [Indexed: 01/06/2023] Open
Abstract
Tumor-targeting contrast agents may facilitate resection of solid neoplasms during fluorescence-guided surgery. Preliminary safety and imaging efficacy of the near-infrared fluorescent probe DA364 were evaluated during surgical resection of spontaneous solid tumors in 24 dogs. Intra-operative imaging was performed in situ and on excised specimens to evaluate fluorescence intensities of tumor and adjacent tissues. After standard-of-care tumor resection, the wound bed was imaged again, and additional tissue was excised if residual fluorescence was detected. DA364 was well tolerated after intravenous administration. The median tumor-to-background ratio in situ for mammary tumors, mast cell tumors and sarcomas was 1.8 (range 1.2–3.9), 2.2 (range 1.0–5.6), and 4.2 (range 2.0–4.3), respectively. Qualitative intra-operative tumor identification was feasible in half of the cases. Remaining fluorescence was detected in four wound beds that contained residual disease, and in11 tumor-free wound beds, confirmed by histopathology. Overall, DA364 did not raise safety concerns and showed accumulation in different types of spontaneous tumors, showing potential to pinpoint residual disease. Larger clinical trials are necessary to select accurate dosing and imaging protocols for specific indications to evaluate the sensitivity and specificity of the agent.
Collapse
Affiliation(s)
- Sophie Favril
- Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.,Cancer Research Institute Ghent, Ghent, Belgium
| | - Chiara Brioschi
- Bracco Imaging SpA, c/o BioIndustry Park, Colleretto Giacosa, Italy
| | - Katrien Vanderperren
- Department of Veterinary Medical Imaging and Small Animal Orthopaedics, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
| | - Eline Abma
- Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.,Cancer Research Institute Ghent, Ghent, Belgium
| | - Emmelie Stock
- Department of Veterinary Medical Imaging and Small Animal Orthopaedics, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
| | - Nausikaa Devriendt
- Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
| | - Ingeborgh Polis
- Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
| | - Hilde De Cock
- Medvet/Algemeen Medisch Laboratorium, Antwerpen, Belgium
| | - Alessia Cordaro
- Bracco Imaging SpA, c/o BioIndustry Park, Colleretto Giacosa, Italy
| | - Luigi Miragoli
- Bracco Imaging SpA, c/o BioIndustry Park, Colleretto Giacosa, Italy
| | - Paolo Oliva
- Bracco Imaging SpA, c/o BioIndustry Park, Colleretto Giacosa, Italy
| | | | | | | | | | - Fabio Tedoldi
- Bracco Imaging SpA, c/o BioIndustry Park, Colleretto Giacosa, Italy
| | - Francesco Blasi
- Bracco Imaging SpA, c/o BioIndustry Park, Colleretto Giacosa, Italy
| | - Hilde de Rooster
- Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.,Cancer Research Institute Ghent, Ghent, Belgium
| |
Collapse
|
8
|
Pina A, Kadri M, Arosio D, Dal Corso A, Coll JL, Gennari C, Boturyn D. Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake. Chemistry 2020; 26:7492-7496. [PMID: 32227540 DOI: 10.1002/chem.202001115] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Revised: 03/25/2020] [Indexed: 12/13/2022]
Abstract
The use of multimeric ligands is considered as a promising strategy to improve tumor targeting for diagnosis and therapy. Herein, tetrameric RGD (Arg-Gly-Asp) peptidomimetics were designed to target αv β3 integrin-expressing tumor cells. These compounds were prepared by an oxime chemoselective assembly of cyclo(DKP-RGD) ligands and a cyclodecapeptide scaffold, which allows a tetrameric presentation. The resulting tetrameric RGD peptidomimetics were shown to improve αv β3 integrin binding compared with the monomeric form. Interestingly, these compounds were also able to enhance tumor cell endocytosis in the same way as tetrameric RGD peptides. Altogether, the results show the potential of the tetrameric cyclo(DKP-RGD) ligands for in vivo imaging and drug delivery.
Collapse
Affiliation(s)
- Arianna Pina
- Università degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi 19, 20133, Milan, Italy
| | - Malika Kadri
- Institute for Advanced Biosciences, University Grenoble Alpes, INSERM, CNRS, Site Santé, Allée des Alpes, 38700, La Tronche, France
| | - Daniela Arosio
- CNR, Istituto di Scienze e Tecnologie Chimiche (SCITEC) "Giulio Natta", Via C. Golgi, 19, 20133, Milan, Italy
| | - Alberto Dal Corso
- Università degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi 19, 20133, Milan, Italy
| | - Jean-Luc Coll
- Institute for Advanced Biosciences, University Grenoble Alpes, INSERM, CNRS, Site Santé, Allée des Alpes, 38700, La Tronche, France
| | - Cesare Gennari
- Università degli Studi di Milano, Dipartimento di Chimica, Via C. Golgi 19, 20133, Milan, Italy
| | - Didier Boturyn
- Department of Molecular Chemistry, University Grenoble Alpes, CNRS, 570, rue de la chimie, CS 40700, 38041, GRENOBLE Cedex 9, France
| |
Collapse
|
9
|
Lavaud J, Henry M, Gayet P, Fertin A, Vollaire J, Usson Y, Coll JL, Josserand V. Noninvasive monitoring of liver metastasis development via combined multispectral photoacoustic imaging and fluorescence diffuse optical tomography. Int J Biol Sci 2020; 16:1616-1628. [PMID: 32226306 PMCID: PMC7097915 DOI: 10.7150/ijbs.40896] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2019] [Accepted: 02/18/2020] [Indexed: 12/16/2022] Open
Abstract
Rationale:In vivo molecular imaging in preclinical animal models is a tool of choice for understanding the pathophysiological mechanisms involved in cancer development and for conducting drug development research. Moreover, combining several imaging modalities can provide multifaceted, complementary and cross-validated information. Photoacoustic imaging (PAI) is a promising imaging modality that can reflect blood vasculature and tissue oxygenation as well as detect exogenous molecules, but one shortcoming of PAI is a lack of organic photoacoustic contrast agents capable of providing tumor contrast. Methods: In the present study, we designed an animal model of liver metastases from colon cancer and monitored metastasis development by in vivo bioluminescence and X-ray microcomputed tomography. Contrast-agent-free PAI was used to detect the respective amounts of oxy- and deoxyhemoglobin and, thus, liver tissue oxygenation. two contrast agents, Angiostamp800 and indocyanin green (ICG), respectively with and without tumor targeting specificity, were then evaluated for their dual fluorescence and photoacoustic detectability and were then used for combined PAI and fluorescence diffuse optical tomography (fDOT) at various disease development stages. Findings: Contrast-agent-free PAI reflected tumor angiogenesis and gradual hypoxia during metastasis development. Multispectral PAI enabled noninvasive real-time monitoring of ICG blood pharmacokinetics, which demonstrated tumor-related liver dysfunction. Both PAI and fluorescence ICG signals were clearly modified in metastasis-bearing livers but did not allow for differentiation between different disease stages. In contrast, there was a significant improvement achieved by using the tumor-specific marker Angiostamp800, which provided gradually increasing PAI and fDOT signals during metastasis development. Conclusion: We demonstrated for the first time the value of using Angiostamp800 as a bimodal tumor-targeting contrast agent for combined PAI and fluorescence imaging of liver metastasis progression in vivo.
Collapse
Affiliation(s)
- Jonathan Lavaud
- OPTIMAL, Small animal Imaging Platform, F-38000 Grenoble, France.,INSERM U1209, CNRS UMR5309, Univ. Grenoble Alpes, Institute for Advanced Biosciences, F-38000 Grenoble, France
| | - Maxime Henry
- OPTIMAL, Small animal Imaging Platform, F-38000 Grenoble, France.,INSERM U1209, CNRS UMR5309, Univ. Grenoble Alpes, Institute for Advanced Biosciences, F-38000 Grenoble, France
| | | | - Arnold Fertin
- CNRS UMR5525 ; TIMC-IMAG, Univ. Grenoble Alpes, F-38000 Grenoble, France
| | - Julien Vollaire
- OPTIMAL, Small animal Imaging Platform, F-38000 Grenoble, France.,INSERM U1209, CNRS UMR5309, Univ. Grenoble Alpes, Institute for Advanced Biosciences, F-38000 Grenoble, France
| | - Yves Usson
- CNRS UMR5525 ; TIMC-IMAG, Univ. Grenoble Alpes, F-38000 Grenoble, France
| | - Jean-Luc Coll
- OPTIMAL, Small animal Imaging Platform, F-38000 Grenoble, France.,INSERM U1209, CNRS UMR5309, Univ. Grenoble Alpes, Institute for Advanced Biosciences, F-38000 Grenoble, France
| | - Véronique Josserand
- OPTIMAL, Small animal Imaging Platform, F-38000 Grenoble, France.,INSERM U1209, CNRS UMR5309, Univ. Grenoble Alpes, Institute for Advanced Biosciences, F-38000 Grenoble, France
| |
Collapse
|
10
|
Borbély A, Thoreau F, Figueras E, Kadri M, Coll J, Boturyn D, Sewald N. Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates. Chemistry 2020; 26:2602-2605. [PMID: 31943410 PMCID: PMC7064988 DOI: 10.1002/chem.201905437] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2019] [Indexed: 01/28/2023]
Abstract
The effective delivery of cytotoxic agents to tumor cells is a key challenge in anticancer therapy. Multivalent integrinspecific ligands are considered a promising tool to increase the binding affinity, selectivity, and internalization efficiency of small-molecule drug conjugates. Herein, we report the synthesis and biological evaluation of a multimeric conjugate containing the high-affinity integrin αv β3 binding ligand RAFT-c(RGDfK)4 , a lysosomally cleavable Val-Cit linker, and cryptophycin-55 glycinate, a potent inhibitor of tubulin polymerization. In vitro cytotoxicity assays verified that the multimeric RGD-cryptophycin conjugate displays improved potency compared to the monomeric analogue in integrin αv β3 overexpressing tumor cell lines, while significantly reduced activity was observed in the integrin-negative cell line.
Collapse
Affiliation(s)
- Adina Borbély
- Organic and Bioorganic ChemistryDepartment of ChemistryBielefeld UniversityUniversitätsstraße 2533615BielefeldGermany
| | - Fabien Thoreau
- CNRS, Department of Molecular ChemistryUniversity Grenoble Alpes, UMR 525038000GrenobleFrance
| | - Eduard Figueras
- Organic and Bioorganic ChemistryDepartment of ChemistryBielefeld UniversityUniversitätsstraße 2533615BielefeldGermany
| | - Malika Kadri
- Institute for Advanced BiosciencesUniversity Grenoble Alpes, INSERM U1209—UMR CNRS 530938700GrenobleFrance
| | - Jean‐Luc Coll
- Institute for Advanced BiosciencesUniversity Grenoble Alpes, INSERM U1209—UMR CNRS 530938700GrenobleFrance
| | - Didier Boturyn
- CNRS, Department of Molecular ChemistryUniversity Grenoble Alpes, UMR 525038000GrenobleFrance
| | - Norbert Sewald
- Organic and Bioorganic ChemistryDepartment of ChemistryBielefeld UniversityUniversitätsstraße 2533615BielefeldGermany
| |
Collapse
|
11
|
Qu Z, Shen J, Li Q, Xu F, Wang F, Zhang X, Fan C. Near-IR emissive rare-earth nanoparticles for guided surgery. Theranostics 2020; 10:2631-2644. [PMID: 32194825 PMCID: PMC7052904 DOI: 10.7150/thno.40808] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2019] [Accepted: 11/01/2019] [Indexed: 12/11/2022] Open
Abstract
Intraoperative image-guided surgery (IGS) has attracted extensive research interests in determination of tumor margins from surrounding normal tissues. Introduction of near infrared (NIR) fluorophores into IGS could significantly improve the in vivo imaging quality thus benefit IGS. Among the reported NIR fluorophores, rare-earth nanoparticles exhibit unparalleled advantages in disease theranostics by taking advantages such as large Stokes shift, sharp emission spectra, and high chemical/photochemical stability. The recent advances in elements doping and morphologies controlling endow the rare-earth nanoparticles with intriguing optical properties, including emission span to NIR-II region and long life-time photoluminescence. Particularly, NIR emissive rare earth nanoparticles hold advantages in reduction of light scattering, photon absorption and autofluorescence, largely improve the performance of nanoparticles in biological and pre-clinical applications. In this review, we systematically compared the benefits of RE nanoparticles with other NIR probes, and summarized the recent advances of NIR emissive RE nanoparticles in bioimaging, photodynamic therapy, drug delivery and NIR fluorescent IGS. The future challenges and promises of NIR emissive RE nanoparticles for IGS were also discussed.
Collapse
|
12
|
Bouclier C, Simon M, Laconde G, Pellerano M, Diot S, Lantuejoul S, Busser B, Vanwonterghem L, Vollaire J, Josserand V, Legrand B, Coll JL, Amblard M, Hurbin A, Morris MC. Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth. Am J Cancer Res 2020; 10:2008-2028. [PMID: 32104498 PMCID: PMC7019173 DOI: 10.7150/thno.40971] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2019] [Accepted: 11/19/2019] [Indexed: 12/25/2022] Open
Abstract
CDK4/cyclin D kinase constitutes an attractive pharmacological target for development of anticancer therapeutics, in particular in KRAS-mutant lung cancer patients, who have a poor prognosis and no targeted therapy available yet. Although several ATP-competitive inhibitors of CDK4 have been developed for anticancer therapeutics, they suffer from limited specificity and efficacy. Methods: As an alternative to ATP-competitive inhibitors we have designed a stapled peptide to target the main interface between CDK4 and cyclin D, and have characterized its physico-chemical properties and affinity to bind cyclin D1. Results: We have validated a positive correlation between CDK4/cyclin D level and KRAS mutation in lung cancer patients. The stapled peptide enters cells rapidly and efficiently, and inhibits CDK4 kinase activity and proliferation in lung cancer cells. Its intrapulmonary administration in mice enables its retention in orthotopic lung tumours and complete inhibition of their growth when co-administered with Abemaciclib. Conclusion: The stapled peptide targeting the main interface between CDK4 and cyclin D provides promising therapeutic perspectives for patients with lung cancer.
Collapse
|
13
|
Holt D, Singhal S, Selmic LE. Near-infrared imaging and optical coherence tomography for intraoperative visualization of tumors. Vet Surg 2020; 49:33-43. [PMID: 31609011 PMCID: PMC11059208 DOI: 10.1111/vsu.13332] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2019] [Revised: 08/30/2019] [Accepted: 09/09/2019] [Indexed: 12/14/2022]
Abstract
Surgical excision is the foundation of treatment for early-stage solid tumors in man and companion animals. Complete excision with appropriate margins of surrounding tumor-free tissue is crucial to survival. Intraoperative imaging allows real-time visualization of tumors, assessment of surgical margins, and, potentially, lymph nodes and satellite metastatic lesions, allowing surgeons to perform complete tumor resections while sparing surrounding vital anatomic structures. This Review will focus on the use of near-infrared imaging and optical coherence tomography for intraoperative tumor visualization.
Collapse
Affiliation(s)
- David Holt
- Department of Clinical Sciences and Advanced Medicine, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania
| | - Sunil Singhal
- Department of Thoracic Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
| | - Laura E Selmic
- Department of Veterinary Clinical Sciences, The Ohio State University College of Veterinary Medicine, Columbus, Ohio
| |
Collapse
|
14
|
Liet B, Laigre E, Goyard D, Todaro B, Tiertant C, Boturyn D, Berthet N, Renaudet O. Multifunctional Glycoconjugates for Recruiting Natural Antibodies against Cancer Cells. Chemistry 2019; 25:15508-15515. [PMID: 31613028 PMCID: PMC6916168 DOI: 10.1002/chem.201903327] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2019] [Revised: 09/05/2019] [Indexed: 01/04/2023]
Abstract
We have developed a fully synthetic and multifunctional antibody-recruiting molecule (ARM) to guide natural antibodies already present in the blood stream against cancer cells without pre-immunization. Our ARM is composed of antibody and tumor binding modules (i.e., ABM and TBM) displaying clustered rhamnose and cyclo-RGD, respectively. By using a stepwise approach, we have first demonstrated the importance of multivalency for efficient recognition with naturel IgM and αv β3 integrin expressing M21 tumor cell line. Once covalently conjugated by click chemistry, we confirmed by flow cytometry and confocal microscopy that the recognition properties of both the ABM and TBM are conserved, and more importantly, that the resulting ARM promotes the formation of a ternary complex between natural IgM and cancer cells, which is required for the stimulation of the cytotoxic immune response in vivo. Due to the efficiency of the synthetic process, a larger diversity of heterovalent ligands could be easily explored by using the same multivalent approach and could open new perspectives in this field.
Collapse
Affiliation(s)
- Benjamin Liet
- DCM, UMR 5250Université Grenoble Alpes, CNRS38000GrenobleFrance
| | - Eugénie Laigre
- DCM, UMR 5250Université Grenoble Alpes, CNRS38000GrenobleFrance
| | - David Goyard
- DCM, UMR 5250Université Grenoble Alpes, CNRS38000GrenobleFrance
| | - Biagio Todaro
- DCM, UMR 5250Université Grenoble Alpes, CNRS38000GrenobleFrance
| | - Claire Tiertant
- DCM, UMR 5250Université Grenoble Alpes, CNRS38000GrenobleFrance
| | - Didier Boturyn
- DCM, UMR 5250Université Grenoble Alpes, CNRS38000GrenobleFrance
| | | | | |
Collapse
|
15
|
Choi N, Jeong HS. Precision surgery for cancer: a new surgical concept in individual tumor biology-based image-guided surgery. PRECISION AND FUTURE MEDICINE 2019. [DOI: 10.23838/pfm.2019.00072] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
|
16
|
Thoreau F, Vanwonterghem L, Henry M, Coll JL, Boturyn D. Design of RGD-ATWLPPR peptide conjugates for the dual targeting of α Vβ 3 integrin and neuropilin-1. Org Biomol Chem 2019; 16:4101-4107. [PMID: 29774910 DOI: 10.1039/c8ob00669e] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Targeting the tumour microenvironment is a promising strategy to detect and/or treat cancer. The design of selective compounds that co-target several receptors frequently overexpressed in solid tumours may allow a reliable and selective detection of tumours. Here we report the modular synthesis of compounds encompassing ligands of αVβ3 integrin and neuropilin-1 that are overexpressed in the tumour microenvironment. These compounds were then evaluated through cellular experiments and imaging of tumours in mice. We observed that the peptide that displays both ligands is more specifically accumulating in the tumours than in controls. Simultaneous interaction with αVβ3 integrin and NRP1 induces NRP1 stabilization at the cell membrane surface which is not observed with the co-injection of the controls.
Collapse
Affiliation(s)
- Fabien Thoreau
- Univ. Grenoble Alpes, CNRS, Department of Molecular Chemistry, UMR 5250, F-38000 Grenoble, France.
| | | | | | | | | |
Collapse
|
17
|
Jiang W, Huang L, Mo F, Zhong Y, Xu L, Fu F. Persistent luminescent multifunctional drug delivery nano-platform based on nanomaterial ZnGa2O4:Cr3+,Sn4+ for imaging-guided cancer chemotherapy. J Mater Chem B 2019. [DOI: 10.1039/c9tb00109c] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
A novel tumor-targeting and release-controllable drug delivery nano-platform with persistent luminescence was constructed for imaging-guided cancer chemotherapy based on the ZnGa2O4:Cr3+,Sn4+ (ZGCS) nanoparticles.
Collapse
Affiliation(s)
- Wenjing Jiang
- Key Laboratory for Analytical Science of Food Safety and Biology of MOE
- Fujian Provincial Key Lab of Analysis and Detection for Food Safety
- College of Chemistry, Fuzhou University
- Fuzhou
- China
| | - Lin Huang
- Key Laboratory for Analytical Science of Food Safety and Biology of MOE
- Fujian Provincial Key Lab of Analysis and Detection for Food Safety
- College of Chemistry, Fuzhou University
- Fuzhou
- China
| | - Fan Mo
- Key Laboratory for Analytical Science of Food Safety and Biology of MOE
- Fujian Provincial Key Lab of Analysis and Detection for Food Safety
- College of Chemistry, Fuzhou University
- Fuzhou
- China
| | - Yingying Zhong
- Key Laboratory for Analytical Science of Food Safety and Biology of MOE
- Fujian Provincial Key Lab of Analysis and Detection for Food Safety
- College of Chemistry, Fuzhou University
- Fuzhou
- China
| | - Liangjun Xu
- Key Laboratory for Analytical Science of Food Safety and Biology of MOE
- Fujian Provincial Key Lab of Analysis and Detection for Food Safety
- College of Chemistry, Fuzhou University
- Fuzhou
- China
| | - FengFu Fu
- Key Laboratory for Analytical Science of Food Safety and Biology of MOE
- Fujian Provincial Key Lab of Analysis and Detection for Food Safety
- College of Chemistry, Fuzhou University
- Fuzhou
- China
| |
Collapse
|
18
|
Favril S, Abma E, Blasi F, Stock E, Devriendt N, Vanderperren K, de Rooster H. Clinical use of organic near-infrared fluorescent contrast agents in image-guided oncologic procedures and its potential in veterinary oncology. Vet Rec 2018; 183:354. [DOI: 10.1136/vr.104851] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2018] [Revised: 04/11/2018] [Accepted: 04/17/2018] [Indexed: 12/15/2022]
Affiliation(s)
- Sophie Favril
- Small Animal Department, Faculty of Veterinary Medicine; Ghent University; Merelbeke Belgium
- Cancer Research Institute Ghent (CRIG); Ghent Belgium
| | - Eline Abma
- Small Animal Department, Faculty of Veterinary Medicine; Ghent University; Merelbeke Belgium
- Cancer Research Institute Ghent (CRIG); Ghent Belgium
| | - Francesco Blasi
- Ephoran Multi-Imaging Solutions s.r.l.; Colleretto Giacosa Italy
| | - Emmelie Stock
- Department of Medical Imaging of Domestic Animals, Faculty of Veterinary Medicine; Ghent University; Merelbeke Belgium
| | - Nausikaa Devriendt
- Small Animal Department, Faculty of Veterinary Medicine; Ghent University; Merelbeke Belgium
| | - Katrien Vanderperren
- Department of Medical Imaging of Domestic Animals, Faculty of Veterinary Medicine; Ghent University; Merelbeke Belgium
| | - Hilde de Rooster
- Small Animal Department, Faculty of Veterinary Medicine; Ghent University; Merelbeke Belgium
- Cancer Research Institute Ghent (CRIG); Ghent Belgium
| |
Collapse
|
19
|
Kajouj S, Marcelis L, Mattiuzzi A, Grassin A, Dufour D, Van Antwerpen P, Boturyn D, Defrancq E, Surin M, De Winter J, Gerbaux P, Jabin I, Moucheron C. Synthesis and photophysical studies of a multivalent photoreactive Ru II-calix[4]arene complex bearing RGD-containing cyclopentapeptides. Beilstein J Org Chem 2018; 14:1758-1768. [PMID: 30112081 PMCID: PMC6071717 DOI: 10.3762/bjoc.14.150] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2018] [Accepted: 06/21/2018] [Indexed: 01/09/2023] Open
Abstract
Photoactive ruthenium-based complexes are actively studied for their biological applications as potential theragnostic agents against cancer. One major issue of these inorganic complexes is to penetrate inside cells in order to fulfil their function, either sensing the internal cell environment or exert a photocytotoxic activity. The use of lipophilic ligands allows the corresponding ruthenium complexes to passively diffuse inside cells but limits their structural and photophysical properties. Moreover, this strategy does not provide any cell selectivity. This limitation is also faced by complexes anchored on cell-penetrating peptides. In order to provide a selective cell targeting, we developed a multivalent system composed of a photoreactive ruthenium(II) complex tethered to a calix[4]arene platform bearing multiple RGD-containing cyclopentapeptides. Extensive photophysical and photochemical characterizations of this Ru(II)–calixarene conjugate as well as the study of its photoreactivity in the presence of guanosine monophosphate have been achieved. The results show that the ruthenium complex should be able to perform efficiently its photoinduced cytotoxic activity, once incorporated into targeted cancer cells thanks to the multivalent platform.
Collapse
Affiliation(s)
- Sofia Kajouj
- Laboratoire de Chimie Organique et Photochimie, Université libre de Bruxelles, Avenue F.D. Roosevelt 50, CP 160/08, 1050 Bruxelles, Belgium
| | - Lionel Marcelis
- Laboratoire de Chimie Organique et Photochimie, Université libre de Bruxelles, Avenue F.D. Roosevelt 50, CP 160/08, 1050 Bruxelles, Belgium.,Engineering of Molecular NanoSystems, Ecole Polytechnique de Bruxelles, Université libre de Bruxelles (ULB), Avenue F.D. Roosevelt 50, CP165/64, B-1050 Brussels, Belgium
| | - Alice Mattiuzzi
- Laboratoire de Chimie Organique, Université libre de Bruxelles, Avenue F.D. Roosevelt 50, CP 160/06, 1050 Bruxelles, Belgium
| | - Adrien Grassin
- Université Grenoble Alpes, Département de Chimie Moléculaire UMR CNRS 5250, CS 40700, 38058 Grenoble Cedex 09, France
| | - Damien Dufour
- Analytical Platform of the Faculty of Pharmacy, Université libre de Bruxelles, Boulevard du Triomphe, Campus de la Plaine, CP205/05, 1050 Bruxelles, Belgium
| | - Pierre Van Antwerpen
- Analytical Platform of the Faculty of Pharmacy, Université libre de Bruxelles, Boulevard du Triomphe, Campus de la Plaine, CP205/05, 1050 Bruxelles, Belgium
| | - Didier Boturyn
- Université Grenoble Alpes, Département de Chimie Moléculaire UMR CNRS 5250, CS 40700, 38058 Grenoble Cedex 09, France
| | - Eric Defrancq
- Université Grenoble Alpes, Département de Chimie Moléculaire UMR CNRS 5250, CS 40700, 38058 Grenoble Cedex 09, France
| | - Mathieu Surin
- Laboratory for Chemistry of Novel Materials, Center for Innovation and Research in Materials and Polymers, University of Mons - UMONS, 20, Place du Parc, B-7000 Mons, Belgium
| | - Julien De Winter
- Organic synthesis and Mass Spectrometry Laboratory, University of Mons - UMONS, Place du Parc 23, B-7000 Mons, Belgium
| | - Pascal Gerbaux
- Organic synthesis and Mass Spectrometry Laboratory, University of Mons - UMONS, Place du Parc 23, B-7000 Mons, Belgium
| | - Ivan Jabin
- Laboratoire de Chimie Organique, Université libre de Bruxelles, Avenue F.D. Roosevelt 50, CP 160/06, 1050 Bruxelles, Belgium
| | - Cécile Moucheron
- Laboratoire de Chimie Organique et Photochimie, Université libre de Bruxelles, Avenue F.D. Roosevelt 50, CP 160/08, 1050 Bruxelles, Belgium
| |
Collapse
|
20
|
Dobson J, de Queiroz GF, Golding JP. Photodynamic therapy and diagnosis: Principles and comparative aspects. Vet J 2018; 233:8-18. [DOI: 10.1016/j.tvjl.2017.11.012] [Citation(s) in RCA: 55] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2017] [Revised: 08/22/2017] [Accepted: 11/21/2017] [Indexed: 12/16/2022]
|
21
|
Near infrared-emitting persistent luminescent nanoparticles for Hepatocellular Carcinoma imaging and luminescence-guided surgery. Biomaterials 2018; 167:216-225. [PMID: 29573651 DOI: 10.1016/j.biomaterials.2018.01.031] [Citation(s) in RCA: 49] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2017] [Revised: 01/19/2018] [Accepted: 01/20/2018] [Indexed: 12/21/2022]
Abstract
Hepatocellular carcinoma (HCC), the fifth most common cancer worldwide, is increasing nowadays and poses a serious threat to human health. However, if treated effectively and timely, it is clinically manageable or curable. Therefore, accurate detection and complete surgical resection remain priorities for HCC with a high potential of improving both survival and quality of life. Lacking of real-time guide technology, traditional surgery are usually relied on the subjective experience of surgeon, which have the limitation of high sensitivity detection tumor. Here, we developed a contrast agent, ZnGa2O4Cr0.004 (ZGC), used for guided surgery during operation to accurate delineation of HCC. ZGC showed excellent long-lasting afterglow properties that lasted for hours, which can aid in real-time guided surgery. Meanwhile, ZGC display high spatial resolution and deep penetration during pre-operation for diagnostic computed tomography (CT). Interestingly, we observed reverse imaging in the tumor region, known as a "dark hole", which further improves the contrast for surgery. This new multi-modality nanoparticle has great potential for accurate liver cancer imaging and resection guidance.
Collapse
|
22
|
Beer P, Pozzi A, Rohrer Bley C, Bacon N, Pfammatter NS, Venzin C. The role of sentinel lymph node mapping in small animal veterinary medicine: A comparison with current approaches in human medicine. Vet Comp Oncol 2017; 16:178-187. [DOI: 10.1111/vco.12372] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2017] [Accepted: 10/17/2017] [Indexed: 12/20/2022]
Affiliation(s)
- P. Beer
- Clinic for Small Animal Surgery, Vetsuisse Faculty; University of Zurich; Zurich Switzerland
| | - A. Pozzi
- Clinic for Small Animal Surgery, Vetsuisse Faculty; University of Zurich; Zurich Switzerland
| | - C. Rohrer Bley
- Division of Radiation Oncology, Vetsuisse Faculty; University of Zurich; Zurich Switzerland
| | - N. Bacon
- Fitzpatrick Referrals Oncology and Soft Tissue; Guildford Hospital; Guildford UK
| | - N. S. Pfammatter
- Clinic for Diagnostic Imaging, Vetsuisse Faculty; University of Zurich; Zurich Switzerland
| | - C. Venzin
- Clinic for Small Animal Surgery, Vetsuisse Faculty; University of Zurich; Zurich Switzerland
| |
Collapse
|
23
|
Huang Y, Fan CQ, Dong H, Wang SM, Yang XC, Yang SM. Current applications and future prospects of nanomaterials in tumor therapy. Int J Nanomedicine 2017; 12:1815-1825. [PMID: 28331307 PMCID: PMC5348070 DOI: 10.2147/ijn.s127349] [Citation(s) in RCA: 46] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Tumors are one of the most serious human diseases and cause numerous global deaths per year. In spite of many strategies applied in tumor therapy, such as radiation therapy, chemotherapy, surgery, and a combination of these treatments, tumors are still the foremost killer worldwide among human diseases, due to their specific limitations, such as multidrug resistance and side effects. Therefore, it is urgent and necessary to develop new strategies for tumor therapy. Recently, the fast development of nanoscience has paved the way for designing new strategies to treat tumors. Nanomaterials have shown great potential in tumor therapy, due to their unique properties, including passive targeting, hyperthermia effects, and tumor-specific inhibition. This review summarizes the recent progress using the innate antitumor properties of metallic and nonmetallic nanomaterials to treat tumors, and related challenges and prospects are discussed.
Collapse
Affiliation(s)
- Yu Huang
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China
| | - Chao-Qiang Fan
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China
| | - Hui Dong
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China
| | - Su-Min Wang
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China
| | - Xiao-Chao Yang
- Department of Biomedical Materials Science, School of Biomedical Engineering, Third Military Medical University, Chongqing, People's Republic of China
| | - Shi-Ming Yang
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China
| |
Collapse
|
24
|
Degardin M, Thakar D, Claron M, Richter RP, Coche-Guérente L, Boturyn D. Development of a selective cell capture and release assay: impact of clustered RGD ligands. J Mater Chem B 2017; 5:4745-4753. [DOI: 10.1039/c7tb00630f] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Clustered RGD compounds improve the selective capture and release of cells that express αvβ3 integrin.
Collapse
Affiliation(s)
- M. Degardin
- Univ. Grenoble-Alpes
- CNRS
- DCM UMR 5250
- F-38000 Grenoble
- France
| | - D. Thakar
- Univ. Grenoble-Alpes
- CNRS
- DCM UMR 5250
- F-38000 Grenoble
- France
| | - M. Claron
- Univ. Grenoble-Alpes
- CNRS
- DCM UMR 5250
- F-38000 Grenoble
- France
| | - R. P. Richter
- University of Leeds
- School of Biomedical Sciences and School of Physics and Astronomy
- Leeds
- UK
- CIC biomaGUNE
| | | | - D. Boturyn
- Univ. Grenoble-Alpes
- CNRS
- DCM UMR 5250
- F-38000 Grenoble
- France
| |
Collapse
|
25
|
Iqbal H, Pan Q. Image guided surgery in the management of head and neck cancer. Oral Oncol 2016; 57:32-9. [DOI: 10.1016/j.oraloncology.2016.04.007] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2015] [Revised: 04/11/2016] [Accepted: 04/12/2016] [Indexed: 12/15/2022]
|
26
|
Josserand V, Kéramidas M, Lavaud J, Righini C, Vollaire J, Bellard E, Rols MP, Teissié J, Coll JL, Golzio M. Electrochemotherapy guided by intraoperative fluorescence imaging for the treatment of inoperable peritoneal micro-metastases. J Control Release 2016; 233:81-7. [PMID: 27155365 DOI: 10.1016/j.jconrel.2016.05.003] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2016] [Revised: 04/25/2016] [Accepted: 05/01/2016] [Indexed: 01/15/2023]
Abstract
Surgery is often the first therapeutic indication in cancer. Patient survival essentially depends on the completeness of tumor resection. This is a major challenge, particularly in patients with peritoneal carcinomatosis (PC), where tumors are widely disseminated in the large peritoneal cavity. These small tumors can be difficult to visualize and are often positioned in delicate locations, further increasing the risk of producing serious tissue/organ damage during their ablation. We propose an innovative therapeutic approach based on intraoperative fluorescence (IF) guided electrochemotherapy (ECT) for the treatment of peritoneal micro-metastases. ECT combines the effects of tissue electro-permeabilization (EP) with the administration of an antimitotic agent (bleomycin) that has poor permeability across intact membranes. IF significantly improves the detection of small tumor lesions. ECT is clinically validated for the treatment of cutaneous tumors in animals and humans, but this is the first time that it has been used along with IF imaging for the targeted treatment of peritoneal metastases in a preclinical model. We set up a murine model of PC that develops secondarily to the resection of a distant primary tumor. Tumor growth and metastasis were finely monitored by non-invasive multimodal imaging (bioluminescence and 3D fluorescence/microCT). Once metastases were detected, mice were randomized into three groups: the ECT group (bleomycin injected intravenously followed by EP) and 2 control groups (bleomycin alone and EP alone). Twenty four hours after the intravenous injection of the tumor targeting agent Angiostamp™700, mice in all groups underwent an abdominal surgery for metastases exploration assisted by fluorescence imaging with the Fluobeam®700 portative device. EP was applied to every nodule detected by IF, except in the bleomycin control group. After surgery, the metastatic invasion was tracked by bioluminescence imaging. In mice treated with bleomycin or EP alone, the metastatic load progressed very rapidly and mice showed no significant difference in lifespan compared to non-operated mice (median lifespan: 27days vs. 25days, respectively). In contrast, the mice treated with ECT displayed a decreased metastatic load and an increased survival rate (median lifespan: 34days). These results provide evidence that IF guided ECT is an effective approach for the treatment of inoperable intraperitoneal micro-metastases.
Collapse
Affiliation(s)
- V Josserand
- INSERM U1209, Institut Albert Bonniot, F-38000 Grenoble, France; Univ. Grenoble Alpes, Institut Albert Bonniot, F-38000 Grenoble, France
| | - M Kéramidas
- INSERM U1209, Institut Albert Bonniot, F-38000 Grenoble, France; Univ. Grenoble Alpes, Institut Albert Bonniot, F-38000 Grenoble, France
| | - J Lavaud
- INSERM U1209, Institut Albert Bonniot, F-38000 Grenoble, France; Univ. Grenoble Alpes, Institut Albert Bonniot, F-38000 Grenoble, France
| | - C Righini
- INSERM U1209, Institut Albert Bonniot, F-38000 Grenoble, France; Univ. Grenoble Alpes, Institut Albert Bonniot, F-38000 Grenoble, France; CHU, Grenoble, France
| | - J Vollaire
- INSERM U1209, Institut Albert Bonniot, F-38000 Grenoble, France; Univ. Grenoble Alpes, Institut Albert Bonniot, F-38000 Grenoble, France
| | - E Bellard
- CNRS, IPBS, Toulouse, France; Université de Toulouse, UPS, IPBS, Toulouse, France
| | - M P Rols
- CNRS, IPBS, Toulouse, France; Université de Toulouse, UPS, IPBS, Toulouse, France
| | - J Teissié
- CNRS, IPBS, Toulouse, France; Université de Toulouse, UPS, IPBS, Toulouse, France
| | - J L Coll
- INSERM U1209, Institut Albert Bonniot, F-38000 Grenoble, France; Univ. Grenoble Alpes, Institut Albert Bonniot, F-38000 Grenoble, France.
| | - M Golzio
- CNRS, IPBS, Toulouse, France; Université de Toulouse, UPS, IPBS, Toulouse, France.
| |
Collapse
|
27
|
Cabon Q, Sayag D, Texier I, Navarro F, Boisgard R, Virieux-Watrelot D, Ponce F, Carozzo C. Evaluation of intraoperative fluorescence imaging-guided surgery in cancer-bearing dogs: a prospective proof-of-concept phase II study in 9 cases. Transl Res 2016; 170:73-88. [PMID: 26746803 DOI: 10.1016/j.trsl.2015.12.001] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/16/2015] [Revised: 12/04/2015] [Accepted: 12/09/2015] [Indexed: 01/26/2023]
Abstract
The objective was to prospectively evaluate the application of intraoperative fluorescence imaging (IOFI) in the surgical excision of malignant masses in dogs, using a novel lipid nanoparticle contrast agent. Dogs presenting with spontaneous soft-tissue sarcoma or subcutaneous tumors were prospectively enrolled. Clinical staging and whole-body computed tomography (CT) were performed. All the dogs received an intravenous injection of dye-loaded lipid nanoparticles, LipImage 815. Wide or radical resection was realized after CT examination. Real-time IOFI was performed before skin incision and after tumor excision. In cases of radical resection, the lymph nodes (LNs) were imaged. The margin/healthy tissues fluorescence ratio or LN/healthy tissues fluorescence ratio was measured and compared with the histologic margins or LN status. Nine dogs were included. Limb amputation was performed in 3 dogs, and wide resection in 6. No adverse effect was noted. Fluorescence was observed in all 9 of the tumors. The margins were clean in 5 of 6 dogs after wide surgical resection, and the margin/healthy tissues fluorescence ratio was close to 1.0 in all these dogs. Infiltrated margins were observed in 1 case, with a margin/healthy tissues fluorescence ratio of 3.2. Metastasis was confirmed in 2 of 3 LNs, associated with LN/healthy tissues fluorescence ratios of 2.1 and 4.2, whereas nonmetastatic LN was associated with a ratio of 1.0. LipImage 815 used as a contrast agent during IOFI seemed to allow for good discrimination between tumoral and healthy tissues. Future studies are scheduled to evaluate the sensitivity and specificity of IOFI using LipImage 815 as a tracer.
Collapse
Affiliation(s)
- Quentin Cabon
- From the Surgery and Anesthesia Unit, VetAgro-Sup Campus Vétérinaire de Lyon, Marcy l'Etoile, France.
| | - David Sayag
- Clinical Oncology Department, Small Animal Internal Medicine Unit, VetAgro-Sup Campus Vétérinaire de Lyon, Marcy l'Etoile, France
| | - Isabelle Texier
- Université Grenoble Alpes, Grenoble, France; CEA-LETI MINATEC/ DTBS, Grenoble, France.
| | - Fabrice Navarro
- Université Grenoble Alpes, Grenoble, France; CEA-LETI MINATEC/ DTBS, Grenoble, France
| | | | | | - Frédérique Ponce
- Clinical Oncology Department, Small Animal Internal Medicine Unit, VetAgro-Sup Campus Vétérinaire de Lyon, Marcy l'Etoile, France
| | - Claude Carozzo
- From the Surgery and Anesthesia Unit, VetAgro-Sup Campus Vétérinaire de Lyon, Marcy l'Etoile, France
| |
Collapse
|
28
|
Grassin A, Jourdan M, Dumy P, Boturyn D. Influence of Pre-organised Architecture on Cell Adhesion by Using Multivalent RGD Compounds. Chembiochem 2016; 17:515-20. [DOI: 10.1002/cbic.201500495] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2015] [Indexed: 12/13/2022]
Affiliation(s)
- Adrien Grassin
- DCM UMR 5250; Université Grenoble Alpes-CNRS; 570 rue de la Chimie B. P. 53 38041 Grenoble cedex 9 France
| | - Muriel Jourdan
- DCM UMR 5250; Université Grenoble Alpes-CNRS; 570 rue de la Chimie B. P. 53 38041 Grenoble cedex 9 France
| | - Pascal Dumy
- IBMM UMR 5247; Ecole Nationale Supérieure de Chimie de Montpellier; 8 rue de l'École Normale 34090 Montpellier France
| | - Didier Boturyn
- DCM UMR 5250; Université Grenoble Alpes-CNRS; 570 rue de la Chimie B. P. 53 38041 Grenoble cedex 9 France
| |
Collapse
|
29
|
Sayag D, Cabon Q, Texier I, Navarro FP, Boisgard R, Virieux-Watrelot D, Carozzo C, Ponce F. Phase-0/phase-I study of dye-loaded lipid nanoparticles for near-infrared fluorescence imaging in healthy dogs. Eur J Pharm Biopharm 2016; 100:85-93. [PMID: 26777342 DOI: 10.1016/j.ejpb.2016.01.001] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2015] [Revised: 11/28/2015] [Accepted: 01/04/2016] [Indexed: 01/12/2023]
Abstract
Near-infrared (NIR) fluorescence imaging using FDA-approved indocyanine green (ICG) has been the subject of numerous studies during the past few years. It could constitute a potentially exciting new paradigm shift in veterinary oncology, especially to develop in vivo fluorescence imaging diagnostics and surgery guidance methods. The objective of this study was to evaluate the pharmacologic and toxicological characteristics in healthy beagle dogs of LipImage™ 815, a formulation made of NIR-dye-loaded lipid nanoparticles. The initial dosage for the evaluation of biodistribution was extrapolated from data in mice and then adapted to define the more adapted dose (MAD) according to the fluorescence results obtained in 5 dogs using a Fluobeam® 800 imaging device (phase 0 study). A single dose acute toxicity study was then performed (3 dogs, phase I study). Before the systemic administration of LipImage™ 815, the dogs presented a very mild residual fluorescence, particularly in the liver and kidneys. After injection, the plasma fluorescence continuously decreased, and the signal was relatively homogeneously distributed throughout the different organs, though more pronounced in the liver and to a lesser extent in the steroid-rich organs (adrenal, ovaries), intestines, lymph nodes and kidneys. A MAD of 2.0μg/kg was found. No evidence of acute or delayed general, hepatic, renal or hematologic toxicity was observed at 1-fold, 5-fold or 10-fold MAD. The results of this phase-0/phase-I study showed that an optimal dosage of LipImage™ 815 of 2.0μg/kg allowed the achievement of a fluorescence signal suitable for surgery guidance application without any acute side effects.
Collapse
Affiliation(s)
- David Sayag
- Clinical Oncology Department, Small Animal Internal Medicine Unit, VetAgro Sup Campus Vétérinaire de Lyon, 1 avenue Bourgelat, F-69280 Marcy l'Etoile, France.
| | - Quentin Cabon
- Surgery and Anesthesia Unit, VetAgro Sup Campus Vétérinaire de Lyon, 1 avenue Bourgelat, F-69280 Marcy l'Etoile, France
| | - Isabelle Texier
- Univ. Grenoble Alpes, F-38000 Grenoble, France; CEA LETI, MINATEC Campus, Technologies for Healthcare and Biology Division, 17 rue des Martyrs, F-38054 Grenoble, France.
| | - Fabrice P Navarro
- Univ. Grenoble Alpes, F-38000 Grenoble, France; CEA LETI, MINATEC Campus, Technologies for Healthcare and Biology Division, 17 rue des Martyrs, F-38054 Grenoble, France
| | - Raphaël Boisgard
- CEA I2BM SHFJ INSERM U1023, 4 place du Général, Leclerc, 91400 Orsay, France
| | - Dorothée Virieux-Watrelot
- Pathology Unit, VetAgro Sup Campus Vétérinaire de Lyon, 1 avenue Bourgelat, 69280 Marcy l'Etoile, France; ICE 2011-03-101 Research Unit, VetAgro Sup Campus Vétérinaire de Lyon, 1 avenue Bourgelat, 69280 Marcy l'Etoile, France
| | - Claude Carozzo
- Surgery and Anesthesia Unit, VetAgro Sup Campus Vétérinaire de Lyon, 1 avenue Bourgelat, F-69280 Marcy l'Etoile, France; ICE 2011-03-101 Research Unit, VetAgro Sup Campus Vétérinaire de Lyon, 1 avenue Bourgelat, 69280 Marcy l'Etoile, France
| | - Frédérique Ponce
- Clinical Oncology Department, Small Animal Internal Medicine Unit, VetAgro Sup Campus Vétérinaire de Lyon, 1 avenue Bourgelat, F-69280 Marcy l'Etoile, France; ICE 2011-03-101 Research Unit, VetAgro Sup Campus Vétérinaire de Lyon, 1 avenue Bourgelat, 69280 Marcy l'Etoile, France
| |
Collapse
|
30
|
Atallah I, Milet C, Henry M, Josserand V, Reyt E, Coll JL, Hurbin A, Righini CA. Near-infrared fluorescence imaging-guided surgery improves recurrence-free survival rate in novel orthotopic animal model of head and neck squamous cell carcinoma. Head Neck 2015; 38 Suppl 1:E246-55. [PMID: 25546527 DOI: 10.1002/hed.23980] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/18/2014] [Indexed: 11/07/2022] Open
Abstract
BACKGROUND Appropriate animal models are required to test novel therapeutics for head and neck squamous cell carcinoma (HNSCC) such as near-infrared (NIR) imaging-guided surgery. METHODS We developed an optimized animal model of orthotopic HNSCC (in female athymic NMRI (Naval Medical Research Institute) nude mice) with a prolonged survival time. Resection of the orthotopic tumors was performed 30 days after implantation with or without the aid of a miniaturized clinical grade NIR optical imaging device, after systemic administration of a fluorescent RGD-based probe that targets αv β3 integrin. RESULTS NIR optical imaging-guided surgery increased the recurrence-free survival rate by 50% through the detection of fluorescent cancer residues as small as 185 µm; these fragments could remain unidentified if resection was performed exclusively under unaided visual guidance. CONCLUSION NIR optical imaging-guided surgery showed an improved HNSCC tumor resection quality in our optimized orthotopic animal model. © 2015 Wiley Periodicals, Inc. Head Neck 38: E246-E255, 2016.
Collapse
Affiliation(s)
- Ihab Atallah
- INSERM U823, Grenoble Cedex, France.,Joseph Fourier University, Grenoble Cedex, France.,Department of Otolaryngology-Head and Neck Surgery, Grenoble University Hospital, Cedex, France
| | - Clément Milet
- INSERM U823, Grenoble Cedex, France.,Joseph Fourier University, Grenoble Cedex, France
| | - Maxime Henry
- INSERM U823, Grenoble Cedex, France.,Joseph Fourier University, Grenoble Cedex, France
| | - Véronique Josserand
- INSERM U823, Grenoble Cedex, France.,Joseph Fourier University, Grenoble Cedex, France
| | - Emile Reyt
- Joseph Fourier University, Grenoble Cedex, France.,Department of Otolaryngology-Head and Neck Surgery, Grenoble University Hospital, Cedex, France
| | - Jean-Luc Coll
- INSERM U823, Grenoble Cedex, France.,Joseph Fourier University, Grenoble Cedex, France
| | - Amandine Hurbin
- INSERM U823, Grenoble Cedex, France.,Joseph Fourier University, Grenoble Cedex, France
| | - Christian Adrien Righini
- INSERM U823, Grenoble Cedex, France.,Joseph Fourier University, Grenoble Cedex, France.,Department of Otolaryngology-Head and Neck Surgery, Grenoble University Hospital, Cedex, France
| |
Collapse
|
31
|
Swanson KI, Clark PA, Zhang RR, Kandela IK, Farhoud M, Weichert JP, Kuo JS. Fluorescent cancer-selective alkylphosphocholine analogs for intraoperative glioma detection. Neurosurgery 2015; 76:115-23; discussion 123-4. [PMID: 25549194 DOI: 10.1227/neu.0000000000000622] [Citation(s) in RCA: 51] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023] Open
Abstract
BACKGROUND 5-Aminolevulinic acid (5-ALA)-induced tumor fluorescence aids brain tumor resections but is not approved for routine use in the United States. We developed and describe testing of 2 novel fluorescent, cancer-selective alkylphosphocholine analogs, CLR1501 (green) and CLR1502 (near infrared), in a proof-of-principle study for fluorescence-guided glioma surgery. OBJECTIVE To demonstrate that CLR1501 and CLR1502 are cancer cell-selective fluorescence agents in glioblastoma models and to compare tumor-to-normal brain (T:N) fluorescence ratios with 5-ALA. METHODS CLR1501, CLR1502, and 5-ALA were administered to mice with magnetic resonance imaging-verified orthotopic U251 glioblastoma multiforme- and glioblastoma stem cell-derived xenografts. Harvested brains were imaged with confocal microscopy (CLR1501), the IVIS Spectrum imaging system (CLR1501, CLR1502, and 5-ALA), or the Fluobeam near-infrared fluorescence imaging system (CLR1502). Imaging and quantitative analysis of T:N fluorescence ratios were performed. RESULTS Excitation/emission peaks are 500/517 nm for CLR1501 and 760/778 nm for CLR1502. The observed T:N ratio for CLR1502 (9.28±1.08) was significantly higher (P<.01) than for CLR1501 (3.51±0.44 on confocal imaging; 7.23±1.63 on IVIS imaging) and 5-ALA (4.81±0.92). Near-infrared Fluobeam CLR1502 imaging in a mouse xenograft model demonstrated high- contrast tumor visualization compatible with surgical applications. CONCLUSION CLR1501 (green) and CLR1502 (near infrared) are novel tumor-selective fluorescent agents for discriminating tumor from normal brain. CLR1501 exhibits a tumor-to-brain fluorescence ratio similar to that of 5-ALA, whereas CLR1502 has a superior tumor-to-brain fluorescence ratio. This study demonstrates the potential use of CLR1501 and CLR1502 in fluorescence-guided tumor surgery.
Collapse
Affiliation(s)
- Kyle I Swanson
- *Department of Neurological Surgery, ‡Cellular and Molecular Biology Training Program, ¶Department of Radiology, ‖Department Medical Physics, and #Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; §Cellectar Biosciences, Inc, Madison, Wisconsin; **Department of Surgery, National University of Singapore, Singapore
| | | | | | | | | | | | | |
Collapse
|
32
|
Grassin A, Claron M, Boturyn D. Biomolecular Assemblies Combining Two Orthogonal Copper-Mediated Ligations in a One-Pot Reaction. Chemistry 2015; 21:6022-6. [DOI: 10.1002/chem.201500293] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2015] [Indexed: 11/10/2022]
|
33
|
Sandrin L, Thakar D, Goyer C, Labbé P, Boturyn D, Coche-Guérente L. Controlled surface density of RGD ligands for cell adhesion: evidence for ligand specificity by using QCM-D. J Mater Chem B 2015; 3:5577-5587. [DOI: 10.1039/c5tb00420a] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A critical interligand spacing is required to observe selective cell adhesion.
Collapse
Affiliation(s)
- L. Sandrin
- Univ. Grenoble Alpes
- DCM UMR 5250
- F-38000 Grenoble
- France
- CNRS
| | - D. Thakar
- Univ. Grenoble Alpes
- DCM UMR 5250
- F-38000 Grenoble
- France
- CNRS
| | - C. Goyer
- Univ. Grenoble Alpes
- DCM UMR 5250
- F-38000 Grenoble
- France
- CNRS
| | - P. Labbé
- Univ. Grenoble Alpes
- DCM UMR 5250
- F-38000 Grenoble
- France
- CNRS
| | - D. Boturyn
- Univ. Grenoble Alpes
- DCM UMR 5250
- F-38000 Grenoble
- France
- CNRS
| | | |
Collapse
|
34
|
Bu L, Shen B, Cheng Z. Fluorescent imaging of cancerous tissues for targeted surgery. Adv Drug Deliv Rev 2014; 76:21-38. [PMID: 25064553 DOI: 10.1016/j.addr.2014.07.008] [Citation(s) in RCA: 78] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2014] [Revised: 05/29/2014] [Accepted: 07/10/2014] [Indexed: 12/18/2022]
Abstract
To maximize tumor excision and minimize collateral damage are the primary goals of cancer surgery. Emerging molecular imaging techniques have made "image-guided surgery" developed into "molecular imaging-guided surgery", which is termed as "targeted surgery" in this review. Consequently, the precision of surgery can be advanced from tissue-scale to molecule-scale, enabling "targeted surgery" to be a component of "targeted therapy". Evidence from numerous experimental and clinical studies has demonstrated significant benefits of fluorescent imaging in targeted surgery with preoperative molecular diagnostic screening. Fluorescent imaging can help to improve intraoperative staging and enable more radical cytoreduction, detect obscure tumor lesions in special organs, highlight tumor margins, better map lymph node metastases, and identify important normal structures intraoperatively. Though limited tissue penetration of fluorescent imaging and tumor heterogeneity are two major hurdles for current targeted surgery, multimodality imaging and multiplex imaging may provide potential solutions to overcome these issues, respectively. Moreover, though many fluorescent imaging techniques and probes have been investigated, targeted surgery remains at a proof-of-principle stage. The impact of fluorescent imaging on cancer surgery will likely be realized through persistent interdisciplinary amalgamation of research in diverse fields.
Collapse
|
35
|
Atallah I, Milet C, Coll JL, Reyt E, Righini CA, Hurbin A. Role of near-infrared fluorescence imaging in head and neck cancer surgery: from animal models to humans. Eur Arch Otorhinolaryngol 2014; 272:2593-600. [PMID: 25115313 DOI: 10.1007/s00405-014-3224-y] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2014] [Accepted: 07/29/2014] [Indexed: 12/18/2022]
Abstract
Complete resection of head and neck cancers with negative surgical margins improves the prognosis of the disease and decreases the recurrence rate. Near-infrared fluorescence-guided surgery of head and neck cancer is a rapidly evolving field that represents an invaluable tool for tumor detection and resection. Here, we present a literature review of the principles of near-infrared fluorescence imaging and its use in head and neck cancer surgery. We discuss important studies in both animal models and humans that have been carried out up to this point. We also outline the important fluorescent molecules and devices used in head and neck fluorescence imaging-guided surgery. Although near-infrared fluorescence-guided surgery for head and neck cancers showed efficacy in animal models, its use in humans is limited by the small number of fluorescent probes that are approved for clinical use. However, it is considered as a novel surgical aid that helps delineate tumor margins preoperatively and could spare patients from the added morbidity that is associated with additional surgery or chemoradiation. In addition, it is a useful tool to detect sentinel lymph nodes as well as metastatic lymph nodes.
Collapse
Affiliation(s)
- Ihab Atallah
- Albert Bonniot Institute, CRI INSERM/UJF U823, BP170, 38042, Grenoble Cedex 9, France,
| | | | | | | | | | | |
Collapse
|
36
|
Dutour A, Josserand V, Jury D, Guillermet S, Decouvelaere AV, Chotel F, Pointecouteau T, Rizo P, Coll JL, Blay JY. Targeted imaging of α(v)β(3) expressing sarcoma tumor cells in vivo in pre-operative setting using near infrared: a potential tool to reduce incomplete surgical resection. Bone 2014; 62:71-8. [PMID: 24530474 DOI: 10.1016/j.bone.2014.02.004] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/20/2013] [Revised: 02/04/2014] [Accepted: 02/06/2014] [Indexed: 10/25/2022]
Abstract
Tumor size and location along with efficacy of pre-operative imaging are limiting factors for optimal surgical excision for osteosarcoma. Our general hypothesis is that targeting αvβ3 integrin-rich osteosarcoma neoangiogenesis should provide improved delivery of diagnostic compounds and assist surgeons intra operatively using near-infrared imaging techniques. We evaluated in an orthotopic metastatic osteosarcoma in rats the potential of AngioStamp™ targeting αvβ3 integrins and detected intra operatively by near infrared (NIR) illumination (Fluobeam™) as a novel, intra operative imaging technique. To determine the potential of this association in improving tumor and metastasis detection, we compared the quality and sensitivity of tumor/metastasis margin delineation and tumor resection using intra-operative NIR imaging to the ones guided by pre-operative imaging (i.e., MRI subsequently confirmed by histopathological analysis). Chemotherapy being essential in osteosarcoma treatment, we evaluated the capacity of AngioStamp™ to specifically localize to the tumor after chemotherapy treatment. We showed a significantly lesser extent of healthy tissue resection after surgical excision when assessing tumor margin intra operatively using AngioStamp™/Fluobeam™ association compared to pre-operative MRI post-operatively confirmed by histopathological analysis (p<0.01). Importantly, intra-operative NIR illumination of lungs revealed more metastases than were detected by CT Scan or under intra-operative white light examination (p<0.01). Importantly, chemotherapy did not alter AngioStamp™ tumor specific targeting nor the sensitivity of tumor detection. Our preclinical data confirm the potential of intra-operative imaging for improved primary tumor and lung metastasis excision. Based on these promising results, we now propose to evaluate this approach as a mean to improve surgical excision while maintaining tumor control in other sarcoma or tumors overexpressing αvβ3 integrins.
Collapse
Affiliation(s)
- Aurelie Dutour
- Department of Clinical Sciences, Centre Léon Berard, Lyon, France; Centre de Recherche en Cancerologie, UMR, INSERM, U1052-Equipe 11-CLB, Lyon, France.
| | - Veronique Josserand
- Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 823, Institut Albert Bonniot, Grenoble, France; Université Joseph Fourier (UJF), Grenoble, France
| | - Delphine Jury
- Centre de Recherche en Cancerologie, UMR, INSERM, U1052-Equipe 11-CLB, Lyon, France
| | | | | | - Franck Chotel
- Department of Pediatric Orthopedic Surgery, HFME, Lyon, France; University Claude Bernard Lyon 1, Lyon, France
| | - Thomas Pointecouteau
- Centre de Recherche en Cancerologie, UMR, INSERM, U1052-Equipe 11-CLB, Lyon, France
| | | | - Jean Luc Coll
- Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 823, Institut Albert Bonniot, Grenoble, France; Université Joseph Fourier (UJF), Grenoble, France
| | - Jean Yves Blay
- Department of Clinical Sciences, Centre Léon Berard, Lyon, France; Centre de Recherche en Cancerologie, UMR, INSERM, U1052-Equipe 11-CLB, Lyon, France; Department of Medical Oncology, Centre Léon Berard, Lyon, France; University Claude Bernard Lyon 1, Lyon, France
| |
Collapse
|
37
|
Thakar D, Coche-Guérente L, Claron M, Wenk CHF, Dejeu J, Dumy P, Labbé P, Boturyn D. Redox-Driven Host-Guest Interactions Allow the Controlled Release of Captured Cells on RGD-Functionalized Surfaces. Chembiochem 2014; 15:377-81. [DOI: 10.1002/cbic.201300636] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2013] [Indexed: 02/03/2023]
|
38
|
Ulrich S, Boturyn D, Marra A, Renaudet O, Dumy P. Oxime Ligation: A Chemoselective Click-Type Reaction for Accessing Multifunctional Biomolecular Constructs. Chemistry 2013; 20:34-41. [DOI: 10.1002/chem.201302426] [Citation(s) in RCA: 176] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|